Dr. Daniel Morganstein is a Consultant Endocrinologist and Honorary Clinical Senior Lecturer at Imperial College. He studied at Cambridge University and qualified from St Bartholomew's and the Royal London in 1998. He trained in endocrinology on the Hammersmith Rotation and undertook research at Imperial College, where he attained a PhD. Dr. Morganstein specializes in all aspects of diabetes and endocrinology, with particular interests in endocrine tumors, including neuroendocrine tumors, adrenal tumors, paragangliomas, thyroid cancer, including medullary thyroid cancer, and pituitary disease. He has a further interest in managing diabetes during cancer treatment and the hormonal effects of cancer treatments. Dr. Morganstein also provides diabetes and endocrinology services to various institutions. He has published papers in endocrine oncology. His expertise includes parathyroid disease, pituitary disorders, diabetes, adrenal disease, endocrine tumors, endocrine side effects of cancer treatment including immunotherapy, and diabetes management in cancer.